Related Experiment Video
Updated: May 16, 2026
08:41
Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
Published on: June 23, 2023
Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells
Tayaramma Thatava1, Yogish C Kudva, Ramakrishna Edukulla
1Department of Molecular Medicine, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|November 28, 2012
Summary
Generating patient-specific induced pluripotent stem (iPS) cells for type 1 diabetes (T1D) requires careful clonal selection. Not all iPS cell lines consistently differentiate into functional insulin-producing cells, necessitating rigorous quality control for regenerative medicine.
Area of Science:
- Stem Cell Biology
- Regenerative Medicine
- Endocrinology
Background:
- Nuclear reprogramming generates patient-specific induced pluripotent stem (iPS) cells for personalized medicine.
- Establishing bioequivalence criteria for iPS cells and their derivatives is crucial for clinical applications.
- Type 1 diabetes (T1D) offers a model for studying autologous iPS cell potential.
Purpose of the Study:
- To assess the differentiation capacity of multiple human iPS cell clones derived from individual T1D patients.
- To identify variations in differentiation propensity and functional insulin production among iPS clones.
- To determine the criteria for generating homogenous iPS cell pools for T1D therapeutics.
Main Methods:
- Generation of multiple human iPS cell clones from T1D patients.
- Prospective screening using developmental markers and gene expression profiling.
- Guided differentiation towards definitive endoderm, primitive gut tube, and insulin-producing islet-like cells.
Main Results:
- Global gene expression and definitive endoderm differentiation were comparable across iPS clones.
- Significant intrapatient variation was observed in generating primitive gut tube and insulin-producing islet-like cells.
- Successful generation of glucose-responsive insulin-producing cells depended on silencing stemness and inducing specific transcription factors.
Conclusions:
- Comprehensive fingerprinting of individual iPS cell clones is essential for T1D regenerative medicine.
- Clonal variability in differentiation dynamics necessitates careful selection for therapeutic applications.
- Homogenous iPS cell pools are required for reliable diagnostic and therapeutic use in T1D.
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:23Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...